Vaccination programs substantially reduce HPV infections and precancerous cervical lesions

Human papilloma virus (HPV) vaccination programs have substantially reduced the number of infections and precancerous cervical lesions caused by the virus, according to a study published today in The Lancet by researchers from Université Laval and the CHU de Québec-Université Laval Research Centre. Results are so promising that it has now become possible to envision eliminating cervical cancer as a […]

Read more

HPV vaccine coverage is far behind other infant vaccines in many US states

Despite the increasing trends in uptake, the human papillomavirus (HPV) vaccine coverage is far behind other infant vaccines in many states, according to a new study, which describes the trends in HPV vaccine uptake in children in the U.S. Findings from the study will be presented during the Pediatric Academic Societies (PAS) 2019 Meeting, taking place on April 24—May 1 […]

Read more

Study ties cancer-causing HPV to heart disease, too

(HealthDay)—Certain strains of HPV are known to cause cervical cancer and other types of tumors. Now, a new study raises the possibility that they might also contribute to heart disease. Researchers found that among over 63,000 women, those infected with “high-risk” strains of human papillomavirus (HPV) were somewhat more likely to develop heart disease or suffer a stroke over the […]

Read more

High-risk sexually transmitted HPV virus associated with increased CVD risk

Infection with high-risk strains of the human papillomavirus (HPV), which have been linked to cancer, might increase the risk of heart and blood vessel or cardiovascular disease, especially among women with obesity or other cardiovascular risk factors, according to new research in Circulation Research, an American Heart Association journal. While cardiovascular disease has known risk factors—such as cigarette smoking; high […]

Read more

New diagnosis of cancer tumors recognizes for the first time with one hundred percent certainty

Gen-Test, the cancer is revolutionizing the diagnosis A new Test for the diagnosis of cervical cancer, is currently causing in the world of medicine for attention. The new Gen-Test recognized in over 15,000 women all cervical cancers and is thus not only more effective but also cheaper than all the usual Tests – including the cell Smear (Pap Test) and […]

Read more

HPV Ups Cervical Cancer Risk, Even With No Cellular Signs

MONDAY, Dec. 24, 2018 — The presence of certain high-risk human papillomavirus (HPV) types predicts future risk for high-grade cervical cancer even among women with no cellular indications of cancer at baseline, according to a study published online Dec. 10 in Cancer. Maria Fröberg, M.D., Ph.D., from the Karolinska University Hospital and Institute in Stockholm, and colleagues evaluated the impact […]

Read more

Newly developed cancer-Test is achieved for the first time, one hundred percent detection rate

Gen-Test, the cancer is revolutionizing the diagnosis A new Test for the diagnosis of cervical cancer, is currently causing in the world of medicine for attention. The new Gen-Test recognized in over 15,000 women all cervical cancers and is thus not only more effective but also cheaper than all the usual Tests – including the cell Smear (Pap Test) and […]

Read more

Studies Warn Against Minimally Invasive Surgery for Cervical Cancer

Two new studies revealed bad news about minimally invasive surgery for cervical cancer, a widely used procedure performed through small slits in the abdomen instead of a big incision. Compared with the older, open abdominal operation, the minimally invasive approach was more likely to result in recurrence of the cancer and death, researchers found, in the first study that rigorously […]

Read more